From: HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
HHLA2
P
+
−
CD8 status
High(≥ 65)
9(90%)
19 (42.2%)
0.017
Low (< 65)
1(10%)
26 (57.8%)